Vivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study
By: Colorado BioScience Association Date: 02/12/2018
FORT COLLINS, Colorado – February 12, 2018 − Vivaldi Biosciences, based at the Research Innovation Center at Colorado State University and Vienna, Austria, today announced that its deltaFLU infl...
Learn MoreRxRevu Unveils New SwiftRx® Platform at 36th Annual J.P.Morgan Healthcare Conference
By: Colorado BioScience Association Date: 01/10/2018
RxRevu, the industry leader in Prescription Decision Support, will unveil its new SwiftRx® platform while attending the 36th Annual J.P.Morgan Healthcare Conference on January 8th in San Francisco, CA...
Learn MoreARTICULUS BIO TO PRESENT AT 10TH ANNUAL BIOTECH SHOWCASE CONFERENCE DURING JP MORGAN HEALTHCARE WEEK
By: Colorado BioScience Association Date: 01/08/2018
Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 10t...
Learn More